Biohaven Ltd.

NYSE: BHVN · Real-Time Price · USD
15.79
0.08 (0.51%)
At close: Aug 18, 2025, 10:45 AM

Biohaven Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-846.42M -408.17M -570.28M -213.8M
Depreciation & Amortization
7.86M 6.91M 1.39M 1.39M
Stock-Based Compensation
71.96M 28.79M 193.56M 65.64M
Other Working Capital
16.1M 19.74M -34.53M 639K
Other Non-Cash Items
167.34M 16.13M 106.25M 4.52M
Deferred Income Tax
n/a n/a n/a -5.26M
Change in Working Capital
16.81M 24.61M -28.6M 1.66M
Operating Cash Flow
-582.45M -331.73M -297.69M -145.84M
Capital Expenditures
-4.05M -3.05M -41.07M -938K
Cash Acquisitions
391K n/a n/a 1.88M
Purchase of Investments
-745.68M -194.12M -263.72M -193.29M
Sales Maturities Of Investments
504.36M 327M n/a 221.56M
Other Investing Acitivies
n/a n/a n/a -28.27M
Investing Cash Flow
-244.97M 129.83M -304.79M 944K
Debt Repayment
n/a n/a 449.13M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.26M -31.32M 34.66M 395K
Financial Cash Flow
677.77M 211.91M 767.6M 138.45M
Net Cash Flow
-149.58M 9.52M 165.55M -6.45M
Free Cash Flow
-586.5M -334.77M -338.76M -146.78M